Serum samples were collected from children suffering from psychotic forms of autistic disorders – childhood autism (F84.02) and atypical childhood psychosis (F84.11) – and measures of innate and acquired immunity were assessed, i.e., leukocyte elastase activity, α1-proteinase inhibitor, C-reactive protein, and antibodies to nerve growth factor and myelin basic protein. Activation of innate immunity (increases in acute-phase inflammatory protein levels and activities) were seen in childhood psychosis. In more severe mental disorders such as atypical endogenous childhood psychoses, activation of both innate and acquired immunity was seen (increases in anti-neuroantigen antibody levels). A correlation between immunological and clinical measures was seen, which provided grounds for suggesting the involvement of innate and acquired immunity in the development of autistic and cognitive impairments in these children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. M. Bashina, Autism in Childhood [in Russian], Meditsina, Moscow (1999).
V. L. Dotsenko, E. A. Neshkova, and G. A. Yarovaya, “Detection of leukocyte elastase from complexes with plasmin inhibitor by its enzymatic activity with a synthetic substrate,” Vopr. Med. Khimii, 40, No. 3, 20–25 (1994).
T. P. Klyushnik, N. S. Sergienko, E. V. Danilovskaya, et al., “Autoantibodies to nerve growth factor in impairments to the mental development of young children,” Zh. Nevrol. Psikhiat., 6, 44–47 (1999).
V. F. Nartikova and T. S. Paskhina, “A unified method for assay of alpha-1-antitrypsin and alpha-2-macroglobulin activity in human serum (plasma),” Vopr. Med. Khimii, 25, No. 4, 494–499 (1979).
N. V. Simashkova, Atypical Autism in Childhood: Author’s Abstract of Doctoral Thesis in Medical Sciences, Moscow (2006).
N. V. Simashkova, L. P. Yakupova, and T. P. Klyushnik, “Interdisciplinary approaches to the problem of childhood and atypical endogenous autism,” in: Psychiatry and Contemporary Society: Proc. 3rd Congr. of Psychiatrists and Narcologists of the Republic of Belarus [in Russian], December 3–4, 2009, pp. 291–293.
A. S. Tiganov and V. M. Bashina, “Contemporary approaches to understanding autism in childhood,” Zh. Nevrol. Psikhiat., 105, No. 8, 4–13 (2005).
V. P. Chikhonin, A. I. Ryabukhin, and O. I. Gurina, “The question of the mechanisms of autoaggression of antibodies to neurospecific proteins across the blood-brain barrier,” Ros. Psikhiat. Zh., No. 1, 43–45 (1997).
I. V. Shcherbakova, V. G. Kaleda, A. N. Barkhatova, and T. P. Klyushnik, “Markers of endothelial dysfunction in episodic-progressive schizophrenia,” Zh. Nevrol. Psikhiat., No. 3, 43–46 (2005).
D. Armao, M. Kornfeld, E. Y. Estrada, et al., “Neutral proteases and disruption of the blood-brain barrier in rat,” Brain Res., 767, No. 20, 259–264 (1997).
P. Ashwood, S. Wills, and J. Van de Water, “The immune response in autism: a new frontier for autism research,” J. Leukoc. Biol., 80, No. 1, 1–15 (2006).
S. Black, I. Kushner, and D. Samols, “C-reactive protein,” J. Biol. Chem., 279, No. 47, 48487–48490 (2004).
D. T. Fearon and E. M. Locksley, “The instructive role of innate immunity in the acquired immune response,” Science, 272, No. 5258, 50–53 (1996).
C. Gillberg, “Autism spectrum disorders,” in: 16th World Congr. Int. Assoc. for Child and Adolescent Psychiatry and Allied Professions, Berlin, August 22–26, 2004, Darmstadt (2004), p. 3.
K. Hoebe, E. Janssen, and B. Beutler, “The interface between innate and adaptive immunity,” Nat. Immunol., 10, 971–974 (2004).
B. Jankovic and D. Djordjijevic, “Differential appearance of autoantibodies to human brain S-100 protein, neuron specific enolase and myelin basic protein in psychiatric patients,” Int. J. Neurosci., 60, No. 1–2, 119–127 (1991).
D. G. Kirsch, “Infection and autoimmunity as etiological factors in schizophrenia: a review and reappraisal,” Schizophr. Bull., 19, No. 2, 355–370 (1993).
V. Lotter, “Epidemiology of autistic condition in young children in prevalence,” Social Psychiatry, No. 1, 124–137 (1966).
A. D. Luster, “The role of chemokines in linking innate and adaptive immunity,” Curr. Opin. Immunol., 14, No. 1, 129–135 (2002).
Z. Nagy, K. Kolev, E. Csonka, et al., “Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes,” Blood Coagul. Fibrinolysis, 9, No. 6, 471–478 (1998).
E. Schopler and R. Reichler, Psychoeducation Profile, University Park Press (1979).
E. Schopler, R. J. Reichler, R. F. DeVellis, and K. Daly, “Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS),” J. Autism Devl. Disord., 10, No. 1, 91–103 (1980).
A. Shimakura, Y. Kamanaka, Y. Ikeda, et al., “Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion,” Brain Res., 858, No. 1, 55–60 (2000).
M. Torzewski, M. Torzewski, C. Rist, et al., “C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis,” Atheroscler. Thromb. Vasc. Biol., 20, No. 9, 2094–2099 (2000).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 111, No. 8, Iss. 1, August, 2011, pp. 41–45.
Rights and permissions
About this article
Cite this article
Klyushnik, T.P., Androsova, L.V., Simashkova, N.V. et al. The State of Innate and Acquired Immunity in Children with Psychotic Forms of Autistic Spectrum Disorders. Neurosci Behav Physi 43, 84–88 (2013). https://doi.org/10.1007/s11055-012-9695-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-012-9695-7